日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

一项针对未经治疗的转移性胰腺腺癌患者的吉西他滨/白蛋白紫杉醇联合纳武利尤单抗/伊匹木单抗或羟氯喹/伊匹木单抗的1期临床试验的临床和转化结果

O'Reilly, Eileen M; Cabanski, Christopher R; Lyman, Jaclyn P; Wainberg, Zev A; Fisher, George A; Wolff, Robert A; Ko, Andrew H; O'Hara, Mark H; Spencer, Christine N; Yu, Jia Xin; Da Silva, Diane M; Padrón, Lacey J; Arnott, Jamie; Fairchild, Justin; Moore, Jonni S; Peng, Brandon; Hoos, William A; O'Donnell-Tormey, Jill; Boffo, Silvia; Dugan, Ute; Kimmelman, Alec C; Amaravadi, Ravi K; Vonderheide, Robert H

Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma

利用组织细胞肉瘤的比较转录谱分析鉴定免疫抑制候选基因

Lenz, Jennifer A; Peng, Brandon; Assenmacher, Charles-Antoine; King, Austin; Zhang, Paul J; Maki, Robert G; Blanco, M Andres; Radaelli, Enrico; Atherton, Matthew J

Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.

犬B细胞淋巴瘤的免疫分析揭示了预后标志物的跨物种保守性

Didehvar Dillon, Lenz Jennifer A, Peng Brandon, Ghanian Audrey, Jiang Lang, Atherton Matthew J